Listed

CVS HEALTH Corp: Form 10-Q for the period ended Mar 31, 2015

Filed with the SEC on May 1, 2015 and accepted by EDGAR at May 1, 2015, 16:34 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-01-01 to 2015-03-31$36.33bnus-gaap:Revenues
Cost of revenue3 months2015-01-01 to 2015-03-31$30.17bnus-gaap:CostOfRevenue
Gross profit3 months2015-01-01 to 2015-03-31$6.16bnus-gaap:GrossProfit
Operating income3 months2015-01-01 to 2015-03-31$2.13bnus-gaap:OperatingIncomeLoss
Interest expense3 months2015-01-01 to 2015-03-31$137.0mus-gaap:InterestExpense
Income tax3 months2015-01-01 to 2015-03-31$777.0mus-gaap:IncomeTaxExpenseBenefit
Diluted EPS3 months2015-01-01 to 2015-03-31$1.07us-gaap:EarningsPerShareDiluted
Basic EPS3 months2015-01-01 to 2015-03-31$1.08us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2015-01-01 to 2015-03-311,136,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2015-01-01 to 2015-03-31$1.98bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2015-01-01 to 2015-03-31$419.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid3 months2015-01-01 to 2015-03-31$399.0mus-gaap:PaymentsOfDividends
Share repurchases3 months2015-01-01 to 2015-03-31$2.01bnus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2015-03-31$1.52bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-03-31$25.62bnus-gaap:AssetsCurrent
Total assetsAt period end2015-03-31$73.93bnus-gaap:Assets
Current liabilitiesAt period end2015-03-31$19.71bnus-gaap:LiabilitiesCurrent
Short-term borrowingsAt period end2015-03-31$500.0mus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2015-03-31$36.99bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000064803-15-000023. Last ingested by Listed: Nov 6, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.